Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance

Go back to Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance
Abbott Laboratories (NYSE: ABT) Delayed: 106.25 -2.08 (1.92%)
Previous Close $108.33    52 Week High $46.38 
Open $108.36    52 Week Low $36.00 
Day High $108.39    P/E 70.83 
Day Low $105.24    EPS $1.50 
Volume 5,696,107